Live symbol workspace

BMY market intelligence

Chart context, AI evidence, sentiment, related news, and verified outcome history are grouped into one asset dossier.

Current $57.13

Trend Flat

Sentiment Neutral

{# Only render the live technical grid when the AI analysis carries real, non-placeholder data. Sentinel payloads (data_status error/collecting, current_price 0) are handled by the Asset Intelligence Dossier below, which degrades to a calm branded empty state instead of "0%" widgets. #}

Detailed Market Analysis

Key Levels

Support

$54.27

Resistance

$59.99

Volume & Momentum

Volume

Weak

0.8x avg

Momentum

0%

Weak

Technical Context

Current price

$57.13

RSI context

50

Market Sentiment

50

Neutral

Stock Metrics

Daily Vol

0%

VIX Est

20

Weekly

0%

Asset Intelligence Dossier

Provider track record

Not enough scored provider calls yet for this asset.

Confidence trend

32%

▲ 2.2 pts vs previous week

Avg confidence across 9 calls in the last 7 days

What sources say

Neutral 1 article

Bristol Myers Squibb Isn't Nearly as Cheap as It Looks -- Here's the 1 Thing That Could Change That

Insider Trading

Refreshing insider trades from FinViz…

Technical Observations

Refreshing technical observations from FinViz...

BMY News Intelligence (2 articles)

AI-curated news influencing BMY price, sentiment, and trend

Explore All BMY News with AI Analysis

Economy

2 hours, 47 minutes ago

Bristol Myers Squibb Isn't Nearly as Cheap as It Looks -- Here's the 1 Thing That Could Change That

Bristol Myers Squibb's P/E ratio is below the industry average, but you have to take this key fact into consideration …

Impact on BMY: The revelation that Bristol Myers Squibb's apparent cheapness may be misleading could …

Bristol Myers Squibb's low P/E ratio may not accurately reflect its value due to a … Medium (50%)

View full analysis →

Yahoo Finance 50% confidence

Economy

1 month, 2 weeks ago

How Safe is Bristol Myers Squibb's Dividend? Here's My Honest Take.

Bristol Myers Squibb has a well-above-market yield of 4.5% and it appears reasonably safe.

Impact on BMY: The perceived safety of Bristol Myers Squibb's dividend may lead to a …

Bristol Myers Squibb's dividend yield of 4.5% appears reasonably safe, which could attract income-seeking investors … High (70%)

View full analysis →

Yahoo Finance 70% confidence